TW202228688A - 用於神經退化性疾病之症狀緩解或治療之貼附劑 - Google Patents

用於神經退化性疾病之症狀緩解或治療之貼附劑 Download PDF

Info

Publication number
TW202228688A
TW202228688A TW110132068A TW110132068A TW202228688A TW 202228688 A TW202228688 A TW 202228688A TW 110132068 A TW110132068 A TW 110132068A TW 110132068 A TW110132068 A TW 110132068A TW 202228688 A TW202228688 A TW 202228688A
Authority
TW
Taiwan
Prior art keywords
scopolamine
patch
administration
hours
patch according
Prior art date
Application number
TW110132068A
Other languages
English (en)
Chinese (zh)
Inventor
小川孝行
西村健太
上野洋明
谷悠平
荻野美恵子
佐藤公紀
廿日岩久典
三好勝則
井上貴博
Original Assignee
日商耐貝醫藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商耐貝醫藥股份有限公司 filed Critical 日商耐貝醫藥股份有限公司
Publication of TW202228688A publication Critical patent/TW202228688A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW110132068A 2020-08-31 2021-08-30 用於神經退化性疾病之症狀緩解或治療之貼附劑 TW202228688A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-145562 2020-08-31
JP2020145562 2020-08-31

Publications (1)

Publication Number Publication Date
TW202228688A true TW202228688A (zh) 2022-08-01

Family

ID=80353475

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110132068A TW202228688A (zh) 2020-08-31 2021-08-30 用於神經退化性疾病之症狀緩解或治療之貼附劑

Country Status (8)

Country Link
US (1) US20230293510A1 (https=)
EP (1) EP4205744A4 (https=)
JP (1) JP7716111B2 (https=)
CN (1) CN115989025A (https=)
AU (1) AU2021331298A1 (https=)
CA (1) CA3193154A1 (https=)
TW (1) TW202228688A (https=)
WO (1) WO2022045335A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114848613A (zh) * 2022-05-09 2022-08-05 山东中医药大学 一种东莨菪碱可溶性微针贴片及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE10301851A1 (de) * 2003-01-17 2004-07-29 Lts Lohmann Therapie-Systeme Ag Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel
US20070010550A1 (en) * 2005-07-08 2007-01-11 The Board Of Regents Of The University Of Texas Scopolamine to Reduce or Eliminate Hot Flashes, Night Sweats, and Insomnia
US20080090808A1 (en) * 2006-10-17 2008-04-17 Franklin Volvovitz Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction
CN1994307B (zh) 2006-12-12 2010-05-12 中国人民解放军第二军医大学 一种预防有机磷酸酯类化合物中毒的复方经皮给药制剂
CA2726136C (en) * 2008-05-30 2016-11-01 Mylan Laboratories, Inc. Stabilized transdermal drug delivery system
WO2019002208A1 (en) * 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING SCOPOLAMINE AND A SILICONE-TYPE ACRYLIC HYBRID POLYMER
US20220160697A1 (en) * 2019-03-19 2022-05-26 Nobelpharma Co., Ltd. Pharmaceutical composition having excellent drug absorption into the living body and excellent chemical stability

Also Published As

Publication number Publication date
JP7716111B2 (ja) 2025-07-31
EP4205744A4 (en) 2024-09-11
EP4205744A1 (en) 2023-07-05
AU2021331298A1 (en) 2023-03-23
CA3193154A1 (en) 2022-03-03
CN115989025A (zh) 2023-04-18
US20230293510A1 (en) 2023-09-21
WO2022045335A1 (ja) 2022-03-03
JPWO2022045335A1 (https=) 2022-03-03

Similar Documents

Publication Publication Date Title
JP2025108704A (ja) デクスメデトミジン経皮送達デバイスを用いた疼痛管理の方法
TWI704933B (zh) 右美托咪啶經皮輸送裝置及使用其之方法
EP3505161B1 (en) Sublingual pharmaceutical composition of edaravone and (+)-2-borneol
TW201521796A (zh) 用於經皮傳遞三級胺藥物之組合物及方法
WO2018115001A1 (en) Transdermal therapeutic system containing asenapine
US20120309823A1 (en) Percutaneous absorption preparations
WO2003092677A1 (de) Transepikutane darreichungsform zur behandlung des restless leg syndroms
TW201524506A (zh) 包含右美托嘧啶（ｄｅｘｍｅｄｅｔｏｍｉｄｉｎｅ）經皮組成物之疼痛處理用方法及組成物
TW201526927A (zh) 用於經皮輸送非鎮靜量右美托咪啶之方法及組成物
US20170128388A1 (en) Pharmaceutical Patch for Transdermal Administration of Tapentadol
TW202228688A (zh) 用於神經退化性疾病之症狀緩解或治療之貼附劑
US20250275930A1 (en) Transdermal delivery patch for treating pain
CN109310656A (zh) 尿毒症性瘙痒症的治疗
JP7109093B2 (ja) リドカインおよびジクロフェナクを含む医薬用貼付剤についての投与計画
JP6459148B2 (ja) 経皮吸収型製剤
HK40088055A (zh) 用於缓解或治疗神经退行性疾病的症状的贴剂
KR102455157B1 (ko) 로피니롤 경피흡수제
US20230028539A1 (en) Pharmaceutical composition, complementary kit and application thereof
KR101964295B1 (ko) 피부 자극이 감소된 메만틴 경피전달 시스템
CN117582424A (zh) 右美托咪定经皮组合物、透皮贴剂及其制备方法和应用
US20110151001A1 (en) Pharmaceutical composition for external application containing prochlorperazine
HK40009745B (en) Sublingual pharmaceutical composition of edaravone and (+)-2-borneol
WO2017017452A1 (en) Transdermal delivery system
JPWO2001093868A1 (ja) ブプレノルフィン含有貼付剤